Study paves way for development of macular degeneration cures

A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.

If you want to include this story in your blog, copy and paste this formatted text: